Memantine and Ibuprofen pretreatment exerts anti-inflammatory effect against streptozotocin-induced astroglial inflammat

  • PDF / 1,711,968 Bytes
  • 10 Pages / 595.276 x 790.866 pts Page_size
  • 9 Downloads / 144 Views

DOWNLOAD

REPORT


Inflammopharmacology

ORIGINAL ARTICLE

Memantine and Ibuprofen pretreatment exerts anti‑inflammatory effect against streptozotocin‑induced astroglial inflammation via modulation of NMDA receptor‑associated downstream calcium ion signaling Sandeep K. Mishra1,3,4 · Mahendra Hidau2,3 · Shivika Rai1,3  Received: 8 June 2020 / Accepted: 14 September 2020 © Springer Nature Switzerland AG 2020

Abstract  We had previously reported that neuroinflammation and memory impairment associated with intracerebroventricular streptozotocin (ICV STZ) injection in rats was due to glial activation and modulation of the N-methyl-D-aspartate (NMDA) receptor function. However, the exact role of the NMDA receptor and the molecules associated with downstream calcium ion signaling in STZ-induced astroglial activation is not known. Thus, in the present study, Memantine (an NMDA receptor antagonist) and Ibuprofen (an anti-inflammatory drug) were used as the pharmacological tool to investigate the molecular mechanisms involved in STZ-induced astroglial inflammation. We have studied the effect of STZ (100 μM) treatment for 24 h on NMDA receptor subunits (NR1, NR2A, and NR2B) expression and its associated calcium ion regulated molecules calcium/calmodulin-dependent protein kinase II subunit α (CaMKIIα), cyclic AMP-response element-binding (CREB) protein, Calpain, and Caspase 3. We have found a significant increase in the expression of NR1, NR2B, Calpain, and Caspase 3 expression, whereas a decrease in the level of NR2A, CaMKIIα, and CREB protein expression after 24 h of STZ treatment. These results indicate that STZ altered the NMDA receptor subunit expression and its downstream calcium (­ Ca2+) ion signaling molecules. We have also found that both Memantine (5 µM) and Ibuprofen (200 μM) significantly prevented the STZ-induced change in CaMKIIα, CREB, Calpain, and Caspase 3 expressions in C6 astrocytoma cells. Interestingly, only Memantine (and not Ibuprofen) was able to prevent the changes in NMDA receptor subunit expression in STZ-treated astrocytoma cells. STZ treatment also increased the level of glial fibrillary acidic protein (GFAP), tumor necrosis factor-alpha (TNF-α), inducible nitric oxide synthase (iNOS), and decreased the level of interleukin-10 (IL-10), indicating inflammatory condition, which was restored by both Memantine and Ibuprofen. These results suggest that both Memantine and Ibuprofen exert anti-inflammatory effect against STZ-induced astroglial activation and neuroinflammation via modulation of NMDA receptor-associated downstream calcium signaling cascade. However, only Memantine (not Ibuprofen) was able to revert STZ-induced changes in NMDA receptor subunit expression.

* Shivika Rai [email protected] 1



Division of Pharmacology, CSIR-Central Drug Research Institute (CDRI), Uttar Pradesh, Sector‑10, Jankipuram Extension, Lucknow 226031, India

2



Division of Pharmacokinetics and Metabolism, CSIR-Central Drug Research Institute (CDRI), Uttar Pradesh, Lucknow 226031, India

3

The Academy of Scientific and Innovati